Skip to main content

Table 3 Pain, disability, and quality of life outcomes from the RCT (Williams et al. 2008 [30])

From: The effectiveness of weight loss programs for low back pain: a systematic review

Effect on Pain, Disability, or Quality of Life

Ā 
Ā 

Type of Intervention

Outcome

Within Group Difference (MD, 95% CI)

P-Value

Between group difference (MD, 95% CI)

Pain outcomes

Telephone based advice,

clinical consultation and

healthy lifestyle

coaching

NPRS (baseline to 2, 6, 10, 14, 18, 22 and 26Ā weeks)

Week 2: 0.0 (-0.6 to 0.6)

Week 6: -0.1 (-0.8 to 0.5)

Week 10: 0.6 (0.0 to 1.3)

Week 14: 0.4 (-0.2 to 1.1)

Week 18: 0.8 (0.2 to 1.5)

Week 22: 0.4 (-0.3 to 1.1)

Week 26: 0.08 (-0.04 to 0.21)

ā€‰=ā€‰1.00

ā€‰=ā€‰0.72

ā€‰=ā€‰0.05

ā€‰=ā€‰0.20

ā€‰=ā€‰0.01

ā€‰=ā€‰0.24

ā€‰=ā€‰0.36

Week 2: 0.0 (-0.6 to 0.6)

Week 6: -0.1(-0.8 to 0.5)

Week 10: 0.6 (0.0 to 1.3)

Week 14: 0.4 (-0.2 to 1.1)

Week 18: 0.8 (0.2 to 1.5)

Week 22: 0.4 (-0.3 to 1.1)

Week 26: 0.3 (-0.4 to 1.0)

Week 2 Pā€‰=ā€‰1.00

Week 6 Pā€‰=ā€‰0.72

Week 10 Pā€‰=ā€‰0.05

Week 14 Pā€‰=ā€‰0.20

Week 18 Pā€‰=ā€‰0.01

Week 22 Pā€‰=ā€‰0.24

Week 26 Pā€‰=ā€‰0.36

Control

NPRS (baseline to 2, 6, 10, 14, 18, 22 and 26Ā weeks)

Week 2: -0.4 (-0.9 to 0.1)

Week 6: -0.6 (-1.2 to 0)

Week 10: -0.4 (-1 to 0.2)

Week 14: 0.0 (-0.5 to 0.5)

Week 18: -0.3 (-0.8 to 0.2)

Week 22: -0.6 (-1.2 to 0)

Week 26: -0.5 (-1.1 to 0.1)

Not reported

Disability outcomes

Telephone based advice, clinical consultation and healthy lifestyle coaching

RMDQ (baseline to 6 and 26Ā weeks)

Week 6: 0.8 (-0.6 to 2.2)

Week 26: -0.1 (-1.7 to 1.5)

ā€‰<ā€‰0.05

Week 6:

0.8 (-0.6 to 2.2)

P value not reported

Control

RMDQ (baseline to 6 and 26Ā weeks)

Week 6: 0.0 (-1.6 to 1.6)

Week 26: -1.1 (-3 to 0.8)

Not reported

Week 26:

-0.1 (-1.7 to 1.5)

P value not reported

Quality of life outcomes

Telephone based advice, clinical consultation and healthy lifestyle coaching

SF12.v2 Physical function (Baseline to 6 and 26Ā weeks)*

SF12.v2 Mental function (baseline to 6 and 26Ā weeks)*

Week 6: 0.5 (-2.6 to 3.6)

Week 26: 0.8 (-2.9 to 4.5)

Week 6: -0.1 (-4.4 to 4.2)

Week 26: -0.2 (-5.4 to 5)

Not reported

SF12.v2 Physical function:

Week 6ā€‰=ā€‰-0.3 (-3.0 to 2.4)

Week 26ā€‰=ā€‰-0.6 (-3.5 to 2.4)

Control

SF12.v2 Physical function (Baseline to 6 and 26Ā weeks)

SF12.v2 Mental function (baseline to 6 and 26Ā weeks)

Week 6: 1.1 (-2.2 to 4.4)

Week 26: 1.3 (-2 to 4.6)

Week 6: -1.1 (-5.2 to 3)

Week 26: -1.8 (-6.3 to 2.7)

Not reported

SF12.v2 Mental function:

Week 6ā€‰=ā€‰-0.9 (-4.3 to 2.4)

Week 26ā€‰=ā€‰-1.7 (-5.4 to 2.0)

  1. NPRSĀ numeric pain rating scale, MDĀ mean difference, CIĀ confidence interval, RMDQĀ roland morris disability questionnaire, MDĀ mean difference, CIĀ confidence interval,Ā SF12.v2Ā short form health survey version 2,Ā MD mean difference,Ā CIĀ confidence interval. *Sample size not reported